Artemide- Biliary 01

• Status: aktiv
• Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection
• Kurzinformation
• Anprechpartner:
  Priv. Doz. Dr. med. Jan Peveling-Oberhag
  Telefon: 0711 278 54736
  E-Mail: j.peveling-oberhag@klinikum-stuttgart.de
• Studienzentrale
  Telefon: 0711 278 54961, -54539
  E-Mail: scc-studienzentrale@klinikum-stuttgart.de